MIRENA 52 mg (20 micrograms/24 hours), medicine-releasing intrauterine system 1 intrauterine system
Active ingredients: Levonorgestrel
Commercialized according to BDPMDispensing in France: Prescription only
Medicine-releasing intrauterine system1 intrauterine systemintra-utérine
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MIRENA 52 mg (20 microgrammes/24 heures), dispositif intra-utérin
- Pharmaceutical form
- dispositif
- Route of administration
- intra-utérine
- Presentation description
- 1 plaquette(s) polytéréphtalate (PET) polyéthylène de 1 dispositif(s)
- Marketing authorisation holder
- BAYER HEALTHCARE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Oct 1997
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66349230CIP73392928CIP133400933929282Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVONORGESTRELdispositif | 52 mg · un dispositif | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.